Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape

T Kader, P Hill, EA Rakha, IG Campbell… - Breast Cancer …, 2018 - Springer
Background Atypical ductal hyperplasia (ADH) is a common diagnosis in the
mammographic era and a significant clinical problem with wide variation in diagnosis and …

Radial Scar: a management dilemma

CML Trombadori, A D'Angelo, F Ferrara, A Santoro… - La radiologia …, 2021 - Springer
Radial scar (RS) or complex sclerosing lesions (CSL) if> 10 mm is a benign lesion with an
increasing incidence of diagnosis (ranging from 0.6 to 3.7%) and represents a challenge …

Rapid and low-cost liquid biopsy with ATR-FTIR spectroscopy to discriminate the molecular subtypes of breast cancer

NMP de Souza, BH Machado, LV Padoin, D Prá… - Talanta, 2023 - Elsevier
Breast cancer (BC) is the most prevalent cancer worldwide. The prognosis and survival of
these patients are directly related to the diagnostic stage. Even so, the gold standard …

Management of high-risk breast lesions

M Bahl - Radiologic Clinics, 2021 - radiologic.theclinics.com
More than 10% of breast biopsies performed based on findings at mammography yield
highrisk lesions (HRLs). 1 HRLs refer to a group of heterogeneous lesions that can be …

Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution

X Li, Z Ma, TM Styblo, CA Arciero, H Wang… - Breast cancer research …, 2021 - Springer
Background The management of high-risk breast lesions diagnosed on image-guided core
biopsy remains controversial. We implemented a high-risk breast conference attended by …

[HTML][HTML] High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision

A Harbhajanka, HL Gilmore, BC Calhoun - Modern Pathology, 2022 - Elsevier
The vast majority of image-detected breast abnormalities are diagnosed by percutaneous
core needle biopsy (CNB) in contemporary practice. For frankly malignant lesions …

Automated breast volume scanner (ABVS)-based radiomic nomogram: a potential tool for reducing unnecessary biopsies of BI-RADS 4 lesions

SJ Wang, HQ Liu, T Yang, MQ Huang, BW Zheng, T Wu… - Diagnostics, 2022 - mdpi.com
Improving the assessment of breast imaging reporting and data system (BI-RADS) 4 lesions
and reducing unnecessary biopsies are urgent clinical issues. In this prospective study, a …

Management of B3 lesions—practical issues

AM Shaaban, N Sharma - Current Breast cancer reports, 2019 - Springer
Abstract Purpose of the Review Breast lesions of uncertain malignant potential (B3) are a
heterogeneous group of diagnostic entities that can be associated with atypia. These are …

B3 Lesions at vacuum-assisted breast biopsy under ultrasound or mammography guidance: a single-center experience on 3634 consecutive biopsies

V Girardi, M Guaragni, N Ruzzenenti, F Palmieri… - Cancers, 2021 - mdpi.com
Simple Summary Image-guided biopsy of suspicious findings at mammography or breast
ultrasonography can result in the diagnosis of lesions with uncertain malignant potential (B3 …

Stromal lymphocytes are associated with upgrade of B3 breast lesions

T Kader, E Provenzano, MW Jayawardana… - Breast Cancer …, 2024 - Springer
Various histopathological, clinical and imaging parameters have been evaluated to identify
a subset of women diagnosed with lesions with uncertain malignant potential (B3 or BIRADS …